Tempest Therapeutics, Inc. — All Filings
973 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-12G
10-12G/A
10-K
10-K/A
10-Q
144
3
4
4/A
424B2
424B3
424B5
425
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
D/A
DEF 14A
DEFA14A
DEFM14A
EFFECT
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13D/A | — | 0001931356-26-000013 | Mar 25, 2026 | — |
| 4 | — | 0001931356-26-000011 | Mar 25, 2026 | Mar 24, 2026 |
| 8-K | 8-K | 0001193125-26-118618 | Mar 23, 2026 | Mar 20, 2026 |
| 8-K | 8-K | 0001193125-26-068614 | Feb 25, 2026 | — |
| 8-K | 8-K | 0001193125-26-045543 | Feb 11, 2026 | — |
| SCHEDULE 13D | — | 0001931356-26-000009 | Feb 10, 2026 | — |
| 4 | — | 0001931356-26-000006 | Feb 6, 2026 | Feb 4, 2026 |
| 3 | — | 0001931356-26-000004 | Feb 6, 2026 | Feb 3, 2026 |
| 8-K | 8-K | 0001193125-26-041190 | Feb 6, 2026 | Feb 3, 2026 |
| 4 | — | 0001871563-26-000002 | Jan 28, 2026 | Jan 27, 2026 |
| 4 | — | 0001321402-26-000003 | Jan 28, 2026 | Jan 27, 2026 |
| 4 | — | 0001214505-26-000003 | Jan 28, 2026 | Jan 27, 2026 |
| 4 | — | 0001127430-26-000002 | Jan 28, 2026 | Jan 27, 2026 |
| 8-K | 8-K | 0001193125-26-027203 | Jan 28, 2026 | Jan 27, 2026 |
| SCHEDULE 13G | — | 0001535610-26-000017 | Jan 21, 2026 | — |
| 8-K | 8-K | 0001193125-26-008938 | Jan 9, 2026 | Jan 8, 2026 |
| EFFECT | — | 9999999995-26-000019 | Dec 31, 2025 | — |
| ARS | ARS | 0001140361-25-047055 | Dec 31, 2025 | Dec 31, 2024 |
| DEF 14A | DEF 14A | 0001140361-25-047054 | Dec 31, 2025 | Jan 27, 2026 |
| S-1 | S-1 | 0001193125-25-312887 | Dec 9, 2025 | — |
| PRE 14A | PRE 14A | 0001140361-25-043939 | Dec 2, 2025 | Dec 31, 2025 |
| 8-K | 8-K | 0001193125-25-298604 | Nov 26, 2025 | Nov 24, 2025 |
| 424B5 | 424B5 | 0001193125-25-294736 | Nov 25, 2025 | — |
| DEFA14A | DEFA14A | 0001193125-25-287188 | Nov 19, 2025 | — |
| 8-K | 8-K | 0001193125-25-287163 | Nov 19, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-265946 | Nov 5, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-265937 | Nov 5, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-108261 | Aug 13, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-106558 | Aug 11, 2025 | Jun 30, 2025 |
| 8-K | 8-K | 0000950170-25-106544 | Aug 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-139899 | Jun 12, 2025 | Jun 11, 2025 |
| 424B5 | 424B5 | 0001193125-25-139623 | Jun 12, 2025 | — |
| 8-K | 8-K | 0001193125-25-138802 | Jun 11, 2025 | — |
| 8-K | 8-K | 0001193125-25-137041 | Jun 6, 2025 | Jun 5, 2025 |
| 10-Q | 10-Q | 0000950170-25-070441 | May 13, 2025 | Mar 31, 2025 |
| 8-K | 8-K | 0000950170-25-070416 | May 13, 2025 | — |
| 10-K/A | 10-K/A | 0001193125-25-107127 | Apr 30, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0001193125-25-098817 | Apr 28, 2025 | Apr 24, 2025 |
| 8-K | 8-K | 0001193125-25-085773 | Apr 18, 2025 | Apr 17, 2025 |
| 8-K | 8-K | 0001193125-25-076938 | Apr 9, 2025 | Apr 8, 2025 |
| 8-K | 8-K | 0001193125-25-073987 | Apr 7, 2025 | Apr 4, 2025 |
| S-8 | S-8 | 0001193125-25-065616 | Mar 27, 2025 | — |
| 10-K | 10-K | 0000950170-25-046144 | Mar 27, 2025 | Dec 31, 2024 |
| 8-K | 8-K | 0000950170-25-046055 | Mar 27, 2025 | — |
| SCHEDULE 13D/A | — | 0000950170-25-018140 | Feb 11, 2025 | — |
| 424B5 | 424B5 | 0001193125-25-021851 | Feb 6, 2025 | — |
| EFFECT | — | 9999999995-25-000195 | Jan 27, 2025 | — |
| CORRESP | — | 0001193125-25-012246 | Jan 24, 2025 | — |
| S-3/A | S-3/A | 0001193125-25-012238 | Jan 24, 2025 | — |
| 4 | — | 0001415889-25-000807 | Jan 6, 2025 | Jan 2, 2025 |